Products

Discover nanopore sequencing

Explore products

Discover nanopore sequencing

What can it do? How does it work? Our platform performance and accuracy

Explore products

Prepare Sequence Analyse
Applications

Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications

Research areas

Investigations

Techniques

Research areas

Microbiology Human genetics Microbiome Clinical research Cancer Plant Transcriptome Animal Population genomics COVID-19 Environmental research & conservation Infectious disease

Investigations

Structural variation SNVs and phasing Gene expression Identification Splice variation Assembly Fusion transcripts Epigenetics Single cell Chromatin conformation

Techniques

Whole genome Targeted Whole transcriptome Metagenomics Short fragment mode View all Applications
Store Resources Support About

Company

News & Events

Global partners

About

About us Board members Executive team Investor centre Company history Sustainability Careers Media resources

News & Events

News Events Nanopore Days Blogs

Global partners

Global distributors Japanese dealers Sequencing service providers For partners

NCM 2023: Houston

Find out more
Get started Talk to us Subscribe
Support
HomeAbout usInvestor centre

Reports & presentations

16 November 2023

Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Gordon Sanghera, CEO, will participate in an analyst led fireside chat at 11am ET/ 4pm GMT
19 October 2023 (13:00)

2023 Capital Markets Day, London, UK
12 September 2023

Morgan Stanley Healthcare Conference

Gordon Sanghera CEO, will participate in an analyst led fireside chat at 4:55pm EDT/ 9:55pm BST
6 September 2023

Interim Results for the six months ended 30 June 2023
31 May 2023

Sustainability Report for the year ended 31 December 2022
22 May 2023

London Calling 2023 Technology Update – Analyst and Investor Call

Gordon Sanghera, Chief Executive Officer and Rosemary Sinclair Dokos, Senior VP Product and Programme Management, will host a webcast at 3pm BST/10am EDT to discuss the technology update session from London Calling 2023 and address questions.

Click here to watch the technology update presentation from London Calling
21 March 2023

Annual Results for the year ended 31 December 2022

Management will host a virtual presentation at 12pm GMT / 7am ET.
28 September 2022

Bernstein 19th Annual Pan European Strategic Decisions Conference

Gordon Sanghera CEO, will participate in an analyst led fireside chat at 11am BST/ 6am EST
15 September 2022

BofA Global Healthcare Conference 2022

Gordon Sanghera CEO, will participate in an analyst led fireside chat at 4:45pm BST/11:45am EST
13 September 2022

Interim Results for the six months ended 30 June 2022
22 March 2022

Annual Results for the year ended 31 December 2021
11 January 2022

J.P. Morgan Virtual Healthcare Conference